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INTRODUCTION
Periodic fever has been an enigma to clinicians since the original descrip-
tion by Hobart Reimann."8 A patient with a history of periodic fever and
an abnormality of steroid metabolism led us to investigate the 17-keto-
steroid fractions in plasma and urine. This paper is a report of the relation-
ship between symptoms of periodic disease and an apparently specific ab-
normality of etiocholanolone metabolism.
MATERIALS AND METHODS
Case Histories:
Case 1: W.S. was a 34-year-old physician with a 26-year history of periodic fever.
The febrile episodes were associated with chills, lethargy, anorexia, malaise, de-
pression, headache, muscle pain, and weight loss. The temperature during attacks
ranged from 1000 to 1060 and was usually accompanied by a leukocytosis.
The first attack had occurred at the age of 8 and lasted approximately 6 months. At
the age of 16 he had his most severe attack and was acutely ill with all of the above
symptoms plus hypotension. At this time he was given adrenal cortical extract with
dramatic improvement in his symptoms and sense of well-being. During the ensuing
years he had numerous attacks lasting from 2 to 24 weeks. Investigative procedures
for the diagnosis of fever of undetermined origin had always been negative, and anti-
biotics produced no change in the clinical picture except on those occasions when a
specific infection was present.
In December, 1956, he was seen with complaints of malaise, anorexia, marked
fatigue, and salt craving. He was afebrile at this time. Studies of adrenocortical
function at the University of Virginia Hospital revealed urinary 17-ketosteroids rang-
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ing from 23 to 40 mg. per 24 hours; a fasting plasma 17-hydroxycorticoid level of 20
micrograms per 100 ml. (normal 4-30 micrograms) with no response to 25 mg. of
ACTH intravenously over a 4-hour period on two separate occasions; and a urinary
pregnanediol of 1.57 mg. per 24 hours (normal 0.3 mg.). The serum electrolytes were
normal at this time. The urinary 17-ketosteroids were partially suppressed by the
administration of 2 mg. of 9-a-fluorohydrocortisone daily for 10 days. In March, 1957,
because of his symptomatology and the above laboratory findings he was treated with
37.5 mg. daily of cortisone with definite improvement in his symptoms and sense of
well-being. The tentative diagnosis was adreno-genital syndrome although there was
no history of precocious sexual development. He had noted severe acne since puberty
and body hair was thought to be excessive.
In November, 1957, he had the beginning of another episode of fever which was still
present when he was transferred from the University of Virginia Hospital to the Yale-
New Haven Medical Center in January, 1958. During this attack his fever had reached
1040 F. in spite of as much as 125 mg. of cortisone acetate daily.
The patient appeared healthy except for a pulse of 120 and a moderate fever. The
liver was palpable 4 centimeters below the right costal margin and a spleen tip could
be felt. According to the history these findings had been present since 1932. Firm,
discrete 0.5-1.0 cm. cervical and axillary lymph nodes were also palpable. During his
hospitalization the patient had temperature spikes of 2 to 5 days' duration not relieved
by aspirin, but relieved by cortisone. When ACTH was administered, there was an
exacerbation of the symptoms.
Laboratory studies revealed a leukocytosis of 20 to 30 thousand with a shift to the
left, and hemoglobin values of 10 to 12 grams per cent. Serum total protein was 6.37
gm. per cent with 2.57 gm. of albumin and 3.80 gm. of globulin per 100 cc. Numerous
other laboratory studies including multiple cultures, serologic tests, and searches for
parasites, and lupus erythematosus also were negative. Liver and lymph node biopsies
were normal.
Steroid studies revealed normal urinary pregnanetriol excretion8 (1.6 mg. per 24
hours). The urinary 17-ketosteroids before ACTH were 6.7 mg. and afterwards rose
to 11.1 and 12.8 mg., according to a modified method of Holtorff and Koch.' Ketogenic
steroids before ACTH were excreted at a rate of 15.8 mg. per day and remained at
this level after ACTH.'6
Case 2: M.K., a 44-year-old man, had had repeated attacks every 3 to 4 weeks which
lasted 3 to 4 days. These episodes consisted of vague epigastric distress with radiation
to the right upper quadrant, fever as high as 1030 F., anorexia, and a cough productive
of "cheesylike" sputum. Bronchograms and sputum examinations in the past have
always been normal. During one attack, adrenocorticotropin exacerbated the symptoms,
but either prednisone or cortisone relieved them. The patient's father and brother had
similar symptoms which were never completely investigated.
Physical examination revealed a thin, very apprehensive man complaining of pain in
the right upper quadrant with tenderness to palpation. Blood pressure was 110 systolic
and 70 diastolic. Physical examination was otherwise entirely within normal limits.
The white blood count was 13,600 with a shift to the left with normal eosinophile
counts. Serum total proteins were 7.45 gm. per cent with 3.57 gm. of albumin and
3.88 gm. of globulin per 100 cc. Repeated cultures, skin tests, and agglutinations for a
wide variety of infectious agents were unrevealing.
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METHODS
Plasma:
Blood was obtained from the first patient during the febrile state, and a second
sample was studied 8 weeks later while he was afebrile and receiving 25 mg. of cortisol
daily. A single sample was obtained from the second patient while he was febrile.
About 50 ml. of plasma was obtained in each instance. The plasma proteins were
precipitated with absolute alcohol and centrifuged.' The protein precipitate was
extracted three times with 60 ml. of n-butanol; the alcohol and butanol extracts were
pooled and dried in a rotating vacuum evaporator. The extract was dissolved in 70
per cent methanol and partitioned three times with hexane. The methanol phase was
then concentrated in vacuo to a volume of about 1.0 ml. and streaked onto Whatman
No. 3MM paper, 47 centimeters in length and 10 centimeters wide for electrophoresis.
Electrophoresis was performed in 0.1 molar barbital buffer with 20 per cent alcohol
by volume at pH 8.6 at 400 volts and 20 m.a. for four hours. Twenty microgram
standards of tetrahydrocortisone glucuronide and androsterone sulfate were spotted
adjacent to the streaked extract. The glucuronide standard moved 8.5 centimeters
toward the anode and the sulfate moved 11.0 centimeters toward the anode. The sulfate
bands were located by cutting off the strip and dipping into Zimmermann reagent.1'
Glucuronide band was located by dipping the strip into triphenyltetrazolium chloride
reagent."3 The glucuronide and sulfate bands were cut out from the paper and
eluted with 70 per cent methanol at 36° C. with shaking for two hours. Nonconjugated
steroids which remained at the origin were cut out and eluted with methanol: chloro-
form (1:1) for two hours at 36°.
Paper chromatography was performed using washed Whatman No. 1 paper which
was cut into strips 4 cm. wide and 50 cm. long. Beakers were placed beneath the strips
to collect the effluent flows. The nonconjugated steroids were initially chromatographed
in a Bush B5 system, 50 per cent methanol: benzene' to separate reduced cortico-
steroids from the 19-carbon steroids. The latter, being less polar than the cortico-
steroids, were collected in a beaker and re-chromatographed in System I., benzene :Skel-
lysolve C® :methanol :water (Bush B-3), 33:66:80:20w, along with reference
standards of androsterone, dehydroisoandrosterone, and etiocholanolone. The C-19
steroids were also identified by their mobility in a heptane: propylene glycol system."
The glucuronide eluate was chromatographed in n-butyl acetate, n-butanol, 10 per cent
acetic acid (80:20:100)," along with reference standards of tetrahydrocortisone glu-
curonide and tetrahydrocortisol glucuronide. The sulfate eluates from the electro-
phoresis were chromatographed in System 2, n-butyl acetate: n-butanol: 10 per cent
formic acid (80:20:100) , with reference standards of etiocholanolone sulfate, de-
hydroisoandrosterone sulfate, and androsterone sulfate. The paper chromatograms were
equilibrated for 12 to 16 hours and descending chromatography performed for 6 hours
at 25 270 C.*
The C-19 steroids were identified by their mobility characteristics after staining with
Zimmermann reagent. The glucuronides separated by paper chromatography were
measured by a micro-carbazole test in a Beckman DU spectrophotometer at a wave
length of 530 miu.'
After the C-19 steroid obtained from patient M.K. was purified in the chroma-
tographic systems 1 and 3 (Fig. 2), sublimation in vacuo was performed. The melting
* The heptane-propylene glycol system was run for 24 hours.
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point of the crystalline material thus obtained was measured in a Fisher melting point
apparatus.
Urine:
A 24-hour urine was collected from patient W.S. in the Yale-New Haven Medical
Center when the patient was not on steroids, although he was having an attack of
periodic fever. A second 24-hour urine was collected while the patient was afebrile, 8
weeks later. The urines were hydrolyzed with beef liver beta-glucuronidase, 300 units
per ml. (Ketodase®*) at pH 4.5 (sodium acetate buffer) and 37° C. for 72 hours. At
the end of the incubation period the urine was extracted continuously for 48 hours at
pH 1 (sulfuric acid) with ether. The ether was washed with a solution of 5 per cent
sodium hydroxide until pigment-free and then with water until neutral. The washings
were added to the urine after having been neutralized with sulfuric acid. The urine was
then boiled for 60 minutes and extracted three times manually with equal volumes of
ether. The ether phase was washed as described above, combined with the first extract,
and dried in vacuo. Traces of water were removed with benzene. The crude extract
obtained in this fashion was chromatographed on an alumina column in the gradient
elution system described by Lakshmanan and Lieberman' using 700 ml. of redistilled
benzene and a gradient of 200 ml. of 4 per cent ethanol and benzene. The eluate was
collected in 100 fractions. Zimmermann reactions (Holtorff and Koch) were carried
out on 1 ml. aliquots from each fraction. The tubes corresponding to the peaks of
Zimmermann material obtained in this fashion were then pooled and dried in vacuo.
Identification by infrared spectrophotometry was performed in a Perkin-Elmer double
beam spectrophotometer Model 21. The peaks containing androsterone and etio-
cholanolone were further analyzed for the presence of the delta-9 analogues according
to the method of Bitman et al.'
RESULTS
Plasma:
There was less than 0.3 ug./100 ml. of the glucuronides of tetrahydro-
cortisone and tetrahydrocortisol in the plasma of W.S. during the febrile
phase. The level of the total 17-ketosteroid sulfate was less than 2.0 ug.
in the febrile plasma. Only one 17-ketosteroid was present, i.e., nonconju-
gated etiocholanolone as detected on chromatogram I (Fig. 1). The sul-
fate region from the afebrile plasma of patient W.S., when chromoto-
graphed in System 2 (chromatogram II, Fig. 1), revealed three Zimmer-
mann-reacting areas. The first was an unidentified polar compound. The
other compounds had mobilities identical with those of the pure reference
compounds, dehydroisoandrosterone sulfate (marked D) and androsterone
sulfate (marked A). No unconjugated 17-ketosteroids were detectable in
the plasma drawn during the afebrile phase.
There were no detectable 17-ketosteroid sulfates or glucuronides present
in the plasma of M.K. while he was febrile. On paper chromatography,
*Ketodase®-Warner-Chillcott Co.
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etiocholanolone was recovered from the nonconjugated steroid area of the
electrophoretogram and identified in Systems 1 and 3 (chromatograms III
and V, Fig. 2). The crystalline material
obtained by sublimation from the area
corresponding to etiocholanolone on
chromatogram V (Fig. 2) revealed a
melting point of 149 to 1500 C. The
sulfuric acid spectrum of this substance
in a Cary recording spectrophoto-
meter revealed one peak at 312 mu.
This evidence conclusively identifies
the compound as etiocholanolone. It
is of interest to note that free (non-
pyrogenice) androsterone was also
detected.
Urine:
In the urine of W.S. obtained dur-
ing the afebrile phase there were four
major peaks: androsterone-2.36 mg.,
etiocholanolone-3.97 mg., 11-oxy 17-
ketosteroids plus A\9-11-desoxy-17 ke-
tosteroids-10.5 mg. Androsterone and
etiocholanolone appeared in their char-
acteristic position in the chromatog-
raphy (Fig. 3), and were identified by
their spectra in H2SO4 and infrared
spectrophotometry (Fig. 4). The fe-
brile urine of W.S. revealed one main
peak consisting of etiocholanolone (3.2
mg. per 24 hours). A more polar
compound (11-oxy-17-ketosteroid of
undetermined nature) was also eluted.
Figure 4 shows the fingerprint re-
gion of the infrared spectrum of the
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FIG. 1. The paper chromatography
of plasma 17-ketosteroids. Roman
numerals refer to the number of the
chromatogram. The arabic numbers
refer to the chromatography system
employed.
E = Etiocholanolone
D = Dehydroisoandrosterone
A = Androsterone
System 1-benzene: Skellysolve C®;
methanol; H20 (33:66, 80:20)
System2-butyl acetate; n-butanol;
10 per cent formic acid (80:20:100)
steroid obtained from the urine of W.S. during the febrile period. The
identity of this infrared spectrum with that of etiocholanolone may be seen
by comparison with the superimposed tracing of a pure standard of etiocho-
lanolone. There were no 3-,8-hydroxy 17-ketosteroids present in either
the febrile or afebrile urine of patient W.S.
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DISCUSSION
In both of the patients free (i.e., nonconjugated) etiocholanolone was
demonstrated in the plasma at the time of the symptoms of periodic fever.
In W.S., no free etiocholanolone was found during a period when symp-
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FIG. 2. Paper chromatography of plasma 17-ketosteroids.
E = Etiocholanolone
D = Dehydroisoandrosterone
A = Androsterone
System 1-benzene: Skellysolve C@; methanol, H20 (33:66:80:20)
System 3-heptane, propylene glycol
toms were absent. A somewhat similar situation has been reported in a 7-
year-old boy with the adrenogenital syndrome by Gonzales and Gardner,7
who found elevated total plasma ketosteroids during peculiar periods of
paroxysmal fever, flushing, and pain in the abdomen and head, chilly sen-
sations, prostration, and vomiting.
The demonstration of nonconjugated etiocholanolone appears particu-
larly significant in our patients since in normal individuals 17-ketosteroids
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are present in the plasma only in conjugated form.* It is therefore reason-
able to suggest that the presence of unconjugated etiocholanolone in the
plasma of these patients may be associated in some way with their episodes
of fever, malaise, headache, nausea, myalgia, and prostration.
CHROMATOGRAM
0 FENIILE EPISODE
OF 17- KETOSTEROIDS
Q AFEBRILE EPISODE
20 30 40 50 60
FRACTION
FIG. 3. Fractionation of 24-hour urinary 17-ketosteroids on alumina column. The
shaded areas represent the quantity of 17-ketosteroids obtained from patient W.S. during
the febrile period. The open areas represent the amount of individual 17-ketosteroids
present during an afebrile period.
Kappas, Hellman, Fukushima, and Gallagher"1 reported that the intra-
muscular injection of etiocholanolone to normal human volunteers pro-
duced shaking chills followed by muscular aches and pains, anorexia,
sweating, headache, and fever as high as 1030 F. Leukocytosis with a shift
to the left of the differential count also occurred. When smaller doses of
* Dubrulle and Claeys' measured unconjugated 17-ketosteroids in plasma and found
7-28 ug/100 ml. of plasma in 16 normal adolescents between the ages of 14 and 17. This
finding is contrary to our own observations and those reported by Clayton, Bongiovanni,
and Papadatos' and Migeon and Plagerl' who found that the amount of unconjugated
steroid in plasma to be insignificant or absent.
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etiocholanolone were injected daily, the fever continued for the duration
of the injections without the production of tolerance. Cortisone pretreat-
ment reduced the febrile reaction. The pyrogenic effect of etiocholanolone
was unique, since androsterone (3a-hydroxyandrostane-17-one), epian-
INFRARED SPECTRUM OF ETIOCHOLANOLONE
(SOLV: CS2 CELL: Imm.)
WAVE NUMBER (cI)
I!00 1300 1200 1100 1000 950 900
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7 o 9 10 11
WAVELENGTH MICRONS
FIG. 4. Patient W.S.: Finger-print region of infrared spectrum of etiocholanolone,
the sample refers to the material isolated from the urine during febrile period (Shaded
area. Fig. 3). Ref. Cpnd is the reference compound of pure etiocholanolone.
drosterone (3,3-hydroxyandrostane-17-one), and 3ft-hydroxyetiocholane-
17-one did not produce fever. Segaloff, Bowers, Gordon, Schlosser, and
Murison also report the occurrence of untoward reactions and hyperpyrexia
in 15 of 18 patients with advanced breast carcinoma who received intra-
muscular etiocholanolone.Y It therefore seems likely that the symptoms of
this disease may be produced by the release into the blood stream of endo-
genous unconjugated etiocholanolone.
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This hypothesis is further supported by the observation that adrenocorti-
cotropin aggravates the symptoms while corticosteroids such as cortisone
or prednisone ameliorate them.
The fact that W.S. had a reduced ability to form 17-hydroxycorticoids
and a tendency to excrete increased quantities of urinary 17-ketosteroids,
at least at one time in his course, and that the symptoms were benefitted
by cortisone treatment suggests that he may have a block in the synthesis
of cortisol analogous to that seen in true adrenogenital patients such as
have been described by Wilkins.' One might postulate that in this type
of patient failure to hydroxylate the 21-carbon results ultimately in an
overproduction of A4-androstene, 3, 17-dione which is reduced to etiocho-
lanolone elsewhere in the body (presumably in the liver). This hypothesis
seems unlikely for two reasons: first because in the ordinary adrenogenital
patient no defect in 11-f3-hydroxylation occurs,'0 so that much of the excess
of 17-ketosteroid is hydroxylated on the 11 carbon; this was not the case
in our patients. Moreover, overproduction of etiocholanolone is not, in it-
self, associated with fever, since the conjugated form of the steroid may
be excreted in large quantities without associated symptoms. It appears
that a failure to conjugate the substance must also be present in order for
symptoms to occur.
A more likely hypothesis, therefore, points to the liver as a possible
source of the difficulty. The reduction of androgens normally results in
the production of androsterone and etiocholanolone, which are promptly
conjugated. Our patients may suffer from an episodic inability to conju-
gate the steroids, associated with an increased production of etiocholano-
lone in preference to androsterone as an end product of androgen reduction.
There is no definite evidence of hepatic disease in these patients, but the
hepatic and splenic enlargement in W.S., associated with abnormal plasma
protein patterns in both patients, suggests that other parameters of hepatic
function may be disturbed.
Although etiocholanolone causes fever in human beings, it is not like
bacterial "pyrogen" since no tolerance develops to its administration.'
Moreover, etiocholanolone does not cause fever in rabbits." For these
reasons it seems unlikely that etiocholanolone plays an important part in
the development of ordinary fever in human beings.
SUMMARY
Unconjugated etiocholanolone has been demonstrated in the plasma of
two patients suffering from periodic attacks of fever, malaise, nausea, and
myalgia (periodic disease). The steroid was not present in the uncon-
jugated form between attacks in one of the subjects. The only 17-keto-
403YALE JOURNAL OF BIOLOGY AND MEDICINE Volume 30, June 1958
steroid present in measurable quantities in the urine of one patient during
an attack was etiocholanolone, whereas between attacks a normal distribu-
tion of urinary 17-ketosteroids was present. The nature of the etiocho-
lanolone was proven by chromatographic mobility characteristics, melting
point, sulfuric acid spectrum (in plasma), and these plus infrared spectrum
(in urine). It is proposed that the attacks of periodic fever in these pa-
tients are a result of the presence of unconjugated etiocholanolone in the
plasma. Possible mechanisms for this abnormality are discussed.
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